ArticleDrug safety2026

Current Challenges in Monitoring the Safety and Utilisation of the Glucagon-Like Peptide-1 Receptor Agonists (GLP-1 RAs): A UK Perspective.

Miranda Davies et al.PubMed ↗Publisher ↗

No numbers read from the abstract.